192 related articles for article (PubMed ID: 23062649)
1. Ciliary body lymphangiogenesis in uveal melanoma with and without extraocular extension.
Khan AM; Kagan DB; Gupta N; Navajas EV; Jin YP; Yücel YH
Ophthalmology; 2013 Feb; 120(2):306-10. PubMed ID: 23062649
[TBL] [Abstract][Full Text] [Related]
2. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
[TBL] [Abstract][Full Text] [Related]
3. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension.
Heindl LM; Hofmann TN; Knorr HL; Rummelt C; Schrödl F; Schlötzer-Schrehardt U; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Invest Ophthalmol Vis Sci; 2009 May; 50(5):1988-95. PubMed ID: 19151383
[TBL] [Abstract][Full Text] [Related]
4. Intraocular lymphatics in ciliary body melanomas with extraocular extension: functional for lymphatic spread?
Heindl LM; Hofmann TN; Schrödl F; Holbach LM; Kruse FE; Cursiefen C
Arch Ophthalmol; 2010 Aug; 128(8):1001-8. PubMed ID: 20697000
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
6. Ciliary body lymphangiogenesis.
Heindl LM; Schrödl F; Lütjen-Drecoll E; Cursiefen C
Ophthalmology; 2013 Jul; 120(7):e41-2. PubMed ID: 23823514
[No Abstract] [Full Text] [Related]
7. Identification of lymphatics in the ciliary body of the human eye: a novel "uveolymphatic" outflow pathway.
Yücel YH; Johnston MG; Ly T; Patel M; Drake B; Gümüş E; Fraenkl SA; Moore S; Tobbia D; Armstrong D; Horvath E; Gupta N
Exp Eye Res; 2009 Nov; 89(5):810-9. PubMed ID: 19729007
[TBL] [Abstract][Full Text] [Related]
8. Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions.
Kujala E; Kivelä T
Ophthalmology; 2005 Jun; 112(6):1135-44. PubMed ID: 15885792
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated lymphangiogenesis in the development of conjunctival melanoma.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7074-83. PubMed ID: 21849428
[TBL] [Abstract][Full Text] [Related]
10. Author reply: To PMID 23062649.
Yucel YH; Gupta N; Kagan DB; Khan AM; Navajas EV; Jin YP
Ophthalmology; 2013 Jul; 120(7):e42-3. PubMed ID: 23823515
[No Abstract] [Full Text] [Related]
11. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
[TBL] [Abstract][Full Text] [Related]
12. Lack of ciliary body lymphatics in iridociliary melanocytoma.
Heindl LM; Bucher F; Naumann GO; Cursiefen C
Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):169-71. PubMed ID: 24213841
[No Abstract] [Full Text] [Related]
13. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.
Kyzas PA; Geleff S; Batistatou A; Agnantis NJ; Stefanou D
J Pathol; 2005 Jun; 206(2):170-7. PubMed ID: 15846845
[TBL] [Abstract][Full Text] [Related]
14. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.
Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2471-80. PubMed ID: 10509639
[TBL] [Abstract][Full Text] [Related]
15. Correlation between lymphatic vessel density and microvessel density in cutaneous malignant melanoma.
Toader MP; Ţăranu T; Toader Ş; Chirana A; Ţăranu T
Rom J Morphol Embryol; 2014; 55(1):141-5. PubMed ID: 24715179
[TBL] [Abstract][Full Text] [Related]
16. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
Coupland SE; Campbell I; Damato B
Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
[TBL] [Abstract][Full Text] [Related]
17. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium.
Niakosari F; Kahn HJ; Marks A; From L
Arch Dermatol; 2005 Apr; 141(4):440-4. PubMed ID: 15837861
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma.
Heindl LM; Hofmann-Rummelt C; Adler W; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Apr; 117(4):649-58. PubMed ID: 20346821
[TBL] [Abstract][Full Text] [Related]
19. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity.
Chen X; Maniotis AJ; Majumdar D; Pe'er J; Folberg R
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2533-9. PubMed ID: 12147581
[TBL] [Abstract][Full Text] [Related]
20. Topography of Lymphatic Markers in Human Iris and Ciliary Body.
Kaser-Eichberger A; Schrödl F; Trost A; Strohmaier C; Bogner B; Runge C; Motloch K; Bruckner D; Laimer M; Schlereth SL; Heindl LM; Reitsamer HA
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4943-53. PubMed ID: 26225635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
